Cargando…
Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5
Cancer is the leading cause of death worldwide, and metastasis is the main attribute to cancer death. CXCR4 and its natural ligand CXCL12 have been known to play a critical role in tumorigenesis, angiogenesis and metastasis. Therefore, designing a new CXCR4 antagonist to prevent tumor metastasis wil...
Autores principales: | Fang, Xiaocui, Xie, Hanyi, Duan, Hongyang, Li, Ping, Yousaf, Maryam, Xu, Haiyan, Yang, Yanlian, Wang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549986/ https://www.ncbi.nlm.nih.gov/pubmed/28793338 http://dx.doi.org/10.1371/journal.pone.0182697 |
Ejemplares similares
-
A Nucleus-Targeting WT1 Antagonistic Peptide Encapsulated in Polymeric Nanomicelles Combats Refractory Chronic Myeloid Leukemia
por: Chen, Mengting, et al.
Publicado: (2023) -
Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer
por: Liu, Changliang, et al.
Publicado: (2018) -
Correction: Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer
por: Liu, Changliang, et al.
Publicado: (2019) -
Correction: Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer
por: Liu, Changliang, et al.
Publicado: (2018) -
Targeting the CXCR4/CXCL12 axis with the peptide antagonist E5 to inhibit breast tumor progression
por: Guo, Hua, et al.
Publicado: (2017)